TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR)

CUSIP: 87911B209

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM NEW
Total 13F shares
35,267,095
Share change
+30,713,503
Total reported value
$615,748,172
Put/Call ratio
109%
Price per share
$17.46
Number of holders
75
Value change
+$537,342,969
Number of buys
58
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 87911B209?
CUSIP 87911B209 identifies TKMR - TEKMIRA PHARMACEUTICALS CORP - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) as of Q1 2015

As of 31 Mar 2015, TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,267,095 shares. The largest 10 holders included QVT Financial LP, RA CAPITAL MANAGEMENT, LLC, Falcon Edge Capital LP, FRANKLIN RESOURCES INC, Blue Ridge Capital, L.L.C., D. E. Shaw & Co., Inc., BANK OF MONTREAL /CAN/, HealthCor Management, L.P., Redmile Group, LLC, and RS INVESTMENT MANAGEMENT CO LLC. This page lists 75 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.